Fluvirin Status Uncertain Until March; 2005 Season Possible – Chiron
Executive Summary
Chiron's Fluvirin manufacturing compliance issues are not likely to be resolved during the first quarter of 2005, but the company does expect to begin manufacturing in time to sell the flu vaccine for the 2005-2006 season
You may also be interested in...
Chiron Fluvirin Remediation Plan Includes Hiring Chief Microbiologist
Chiron is hiring a chief microbiologist as part of the firm's remediation plan following the suspension of its license to manufacture Fluvirin at its Liverpool, England plant
ID Biomedical Opens Channel For Fluviral Distribution in U.S.
Henry Schein has committed to purchasing approximately half of all ID Biomedical Fluviral doses produced for the U.S. under a distribution agreement for the flu vaccine unveiled by the companies Dec. 6
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011